References
- De VE, van de Poll-Franse LV, Louwman WJ, De Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005; 152: 481–8
- Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Arch Dermatol. 2000; 136: 1524–30
- Van Iersel CA, van de Velden HV, Kusters CD, Spauwen PH, Blokx WA, Kiemeney LA, et al. Prognostic factors for a subsequent basal cell carcinoma: Implications for follow-up. Br J Dermatol. 2005; 153: 1078–80
- Lear JT, Smith AG, Heagerty AH, Bowers B, Jones PW, Gilford J, et al. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma. Carcinogenesis. 1997; 18: 1499–503
- Lear JT, Heagerty AH, Smith A, Bowers B, Payne CR, Smith CA, et al. Multiple cutaneous basal cell carcinomas: Glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis. 1996; 17: 1891–6
- Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, et al. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res. 1996; 56: 1974–7
- Ramachandran S, Hoban PR, Ichii-Jones F, Pleasants L, Ali-Osman F, Lear JT, et al. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: Association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours. Pharmacogenetics. 2000; 10: 545–56
- Ramachandran S, Lear JT, Ramsay H, Smith AG, Bowers B, Hutchinson PE, et al. Presentation with multiple cutaneous basal cell carcinomas: Association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev. 1999; 8: 61–7
- Kerb R, Brockmöller J, Reum T, Roots I. Deficiency of glutathione S-transferase T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol. 1997; 108: 229–32
- Auepemkiate S, Boonyaphiphat P, Thongsuksai P. p53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma. Histopathology. 2002; 40: 568–73
- Demirkan NC, Colakoglu N, Duzcan E. Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas. Pathol Oncol Res. 2000; 6: 272–4
- Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet. 2001; 68: 884–94
- Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control series. Acad Dermatol. 2006; 54: 290–300
- Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003; 348: 1681–91
- Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? A case–control study in Western Australia. Int J Cancer. 1995; 60: 489–94
- Guidelines. Treatment of patients with basal cell carcinoma. Utrecht: Kwaliteitsinstituut voor de gezondheidszorg CBO; 2003.